Investment Thesis
Co-Diagnostics faces severe financial distress with an 84% revenue collapse, negative gross margins indicating fundamental business model failure, and annual cash burn of approximately $8M against only $8.2M in remaining cash reserves. The deeply negative profitability margins and deteriorating cash position suggest bankruptcy risk and potential total equity loss.
Strengths
- Low leverage with 0.12x debt-to-equity ratio limits refinancing risk and provides covenant flexibility
- Adequate short-term liquidity with 2.28x current ratio provides near-term survival window
- Minimal capital expenditure requirement ($142K) reduces cash outflow from reinvestment needs
Risks
- Catastrophic 84% year-over-year revenue decline indicates fundamental product failure or market collapse
- Negative gross margin of -32.8% means company loses money on every sale; mathematically unsustainable at any volume
- Annual operating cash burn of $7.8M against $8.2M cash reserves creates approximately 12-month runway before insolvency
- Negative gross profit of -$47.8K despite only $146K revenue suggests structural cost problems and possible obsolete inventory
- Zero insider transactions in 90 days suggests management awareness of distress and lack of conviction in recovery
- ROE of -57% and ROA of -42.5% indicate severe shareholder value destruction
Key Metrics to Watch
- Revenue stabilization and recovery trajectory (continued decline is existential threat)
- Gross margin return to positive territory (current -32.8% is unsustainable and indicates non-viable product cost structure)
- Monthly cash burn rate and remaining runway (critical for going concern evaluation and timeline to potential bankruptcy)
- Operating cash flow inflection point (must achieve positive OCF to avoid equity dilution or restructuring)
Financial Metrics
Revenue
146.0K
Net Income
-9.1M
EPS (Diluted)
$-4.06
Free Cash Flow
-8.0M
Total Assets
21.5M
Cash
8.2M
Profitability Ratios
Gross Margin
-32.8%
Operating Margin
-6,309.1%
Net Margin
-6,262.3%
ROE
-57.0%
ROA
-42.5%
FCF Margin
-5,473.2%
Balance Sheet & Liquidity
Current Ratio
2.28x
Quick Ratio
2.09x
Debt/Equity
0.12x
Debt/Assets
25.4%
Interest Coverage
-86.52x
Long-term Debt
1.9M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-16T08:52:52.559550 |
Data as of: 2026-03-31 |
Powered by Claude AI